dual glp 1 gip receptor agonists Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Mechanisms of action and therapeutic

other outcomes were cardiovascular and total death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for heart failure (HHF), and renal outcome

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

This receptor specifically interacts with GLP-1, a key hormone that plays an integral role in regulating blood glucose levels, lipid metabolism, and several other crucial biological functions

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time

HOW TO TAKE GLP-1 STRENGTH: Take 2 capsules once daily, preferably with meals

This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists.GLP-1 Agonists What is it?